Wearable medical technology trial for cancer patients in Manchester

The University of Manchester NHS Foundation Trust, The Christie NHS Foundation Trust, and the University of Manchester working together to test wearable medical technology for cancer patients. Special health sensors will show the progress of patients making digital fingerprints of their vital signs. This will provide doctors with information on how patients deal with cancer and whether it’s possible to advance the recovery. The Enhanced Monitoring for Better Recovery and Cancer Experience (EMBRaCE) trial in Manchester research and assess wearable technology such as smart rings and smartwatches, as they are able to monitor vital signs (heart rate, temperature, physical activity, etc) and are expected to help in cancer care.  Read more

Related Work